By: Parvathy Rajagopal  Aug. 28, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Pueblo, Colorado, showed that St. Mary-Corwin Medical Center and Parkview Medical Center had the best value outcomes over a 90 day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 470: Major Joint Replacement or Reattachment of Lower Extremity without Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.

By: Neha Thomas  Aug. 28, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Toledo, Ohio, showed that St. Luke's Hospital, ProMedica Toledo Hospital, and Mercy Health St.Vincent Medical Center have the best value outcomes over a 90 day episode for Renal Failure. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs, such as ProMedica Health Network, Inc., make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 683: Renal Failure with Complication or Comorbidity (CC), to adjust for complications and comorbidities.

By: Neha Thomas  Aug. 27, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Kalamazoo, Michigan, showed that Bronson Methodist Hospital had the best value outcomes over a 90 day episode for COPD, followed by Ascension Borgess Hospital. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs, such as Federation ACO, LLC, make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 190: Chronic Obstructive Pulmonary Disease with Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.

By: Sruthy Iype  Aug. 27, 2020

Dexur’s analysis of Medicare claims data showed that Remicade was used more in the treatment of patients with rheumatoid arthritis as compared to Crohn’s disease, ulcerative colitis, psoriatic arthritis, and ankylosing spondylitis. The analysis looked at the J code (J1745) usage of the drug among Medicare patients who received outpatient care between Jan and Dec 2019. The analysis also looks at the average claims per patient data, which is a proxy for the number of injections / IV infusions / doses administered to a patient.

By: Neha Thomas  Aug. 27, 2020

Dexur’s analysis of medicare claims of hospitals within a 50-mile radius of Tuscaloosa, Alabama, showed that DCH Regional Medical Center had the best value outcomes over a 90 day episode for Renal Failure, followed by St. Vincent's East and St. Vincent's Birmingham. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 683: Renal Failure with Complication or Comorbidity (CC), to adjust for complications and comorbidities.

By: Parvathy Rajagopal  Aug. 26, 2020

Dexur’s analysis of Medicare claims of hospitals within a 10-mile radius of Beckley, West Virginia showed that Beckley ARH Hospital and Raleigh General Hospital had the best value outcomes over a 90-day episode for Sepsis. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days, including the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. The total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referrals choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 871: Septicemia or Severe Sepsis without MV >96 Hours with Major Complication or Comorbidity, to adjust for complications and comorbidities.

By: Sruthy Iype  Aug. 26, 2020

Dexur’s analysis of Medicare claims data showed that lung cancer patients accounted for more than 50 percent of Keytruda’s usage, followed by patients of melanoma, bladder cancer, head & neck cancer, and kidney cancer. The analysis looked at the J code (J9271) usage of the drug among Medicare patients* who received outpatient care between Jan and Dec 2019. The analysis also looks at the average claims per patient data, which is a proxy for the number of injections / IV infusions / doses administered to a patient.

By: Neha Thomas  Aug. 26, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Montgomery, Alabama, showed that Baptist Medical Center South had the best value outcomes over a 90 day episode for Hip & Knee replacement, followed by Jackson Hospital. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 470: Major Joint Replacement or Reattachment of Lower Extremity without Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.

By: Barsha Nandy  Aug. 25, 2020

Importance of MSPB and other VBP Measures

Dexur analyzes Medicare Claims data to evaluate MSPB cost per episode for hospitals. MSPB Hospital measure assesses the cost to Medicare for services performed by hospitals and other healthcare providers during an episode of care (episode), which is composed of the periods immediately prior to, during, and following a patient’s hospital stay. CMS stresses the importance of measuring the cost of care explicitly to recognize hospitals that are involved in the provision of high-quality care at a lower cost, in conjunction with other quality measures.

By: Sruthy Iype  Aug. 25, 2020

Dexur’s analysis of Medicare claims data showed that Avastin (bevacizumab) was used more in the treatment of patients with colorectal cancer, as compared to ovarian, brain, lung, and fallopian tube cancer. The analysis looked at the J code (J9035) usage of the drug among Medicare patients* who received outpatient care between Jan and Dec 2019. The analysis also looks at the average claims per patient data, which is a proxy for the number of injections / IV infusions / doses administered to a patient.